UK markets closed
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.59 -0.98 (-1.26%) GOLD FUTURES
2,341.90 -51.00 (-2.13%) DOW
39,271.61 -399.43 (-1.01%) Bitcoin GBP
53,466.11 -1,847.34 (-3.34%)
CytomX Therapeutics, Inc. (6C1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 134.96M |
| Enterprise value | 8.36M |
| Trailing P/E | 8.74 |
| Forward P/E | 18.35 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.20 |
| Price/book (mrq) | 4.76 |
| Enterprise value/revenue | 0.08 |
| Enterprise value/EBITDA | 0.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.09 |
| 52-week change 3 | 2.48% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 4.4020 |
| 52-week low 3 | 0.9760 |
| 50-day moving average 3 | 2.0408 |
| 200-day moving average 3 | 1.5254 |
Share statistics
| Avg vol (3-month) 3 | 704 |
| Avg vol (10-day) 3 | 1.18k |
| Shares outstanding 5 | 77.92M |
| Implied shares outstanding 6 | 79.81M |
| Float 8 | 58.39M |
| % held by insiders 1 | 1.03% |
| % held by institutions 1 | 64.51% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 13.87% |
| Operating margin (ttm) | 28.11% |
Management effectiveness
| Return on assets (ttm) | 3.23% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 119.18M |
| Revenue per share (ttm) | 1.53 |
| Quarterly revenue growth (yoy) | 76.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.87M |
| Net income avi to common (ttm) | 16.53M |
| Diluted EPS (ttm) | 0.1900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 150.28M |
| Total cash per share (mrq) | 1.93 |
| Total debt (mrq) | 12.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.16 |
| Book value per share (mrq) | -0.47 |
Cash flow statement
| Operating cash flow (ttm) | -91.43M |
| Levered free cash flow (ttm) | -471.75k |
© 2024 Yahoo. All rights reserved.